Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.26 trillion and total revenue of $109.89 billion.
Market Cap
1.26T
Revenue
109.89B
Profits
-41.36B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.51B | -0.24% | 608,971 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.84B | -0.69% | 260,128 | 14.92B |
| 3 | ARGX | argenx SE | 55.78B | 1.60% | 188,349 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.66B | -3.15% | 2,230,423 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.65B | 1.17% | 558,377 | 4.29B |
| 6 | RPRX | Royalty Pharma plc | 32.48B | -1.21% | 1,020,967 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.67B | -1.78% | 179,642 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 28.30B | 2.32% | 4,733,292 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.64B | 2.65% | 1,830,719 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.62B | -0.91% | 228,505 | 3.23B |
| 11 | INSM | Insmed Incorporated | 23.28B | 2.54% | 1,626,688 | 819.56M |
| 12 | INCY | Incyte Corporation | 22.86B | -0.21% | 526,883 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.84B | 5.80% | 1,780,473 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.65B | 1.66% | 227,380 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.07B | 1.04% | 429,172 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.53B | 3.04% | 1,584,964 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.73B | 0.66% | 622,998 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.28B | -0.40% | 567,137 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.74B | 2.65% | 280,838 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.28B | 1.05% | 168,427 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.64B | 2.70% | 965,848 | 622.01M |
| 22 | CYTK | Cytokinetics, Incorporated | 11.62B | -1.96% | 1,007,028 | 105.82M |
| 23 | SMMT | Summit Therapeutics Inc. | 11.35B | 2.09% | 2,287,704 | - |
| 24 | KRYS | Krystal Biotech, Inc. | 11.11B | -0.36% | 140,258 | 417.30M |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 11.10B | -0.43% | 620,300 | 3.24B |
| 26 | TECH | Bio-Techne Corporation | 11.01B | -0.38% | 7,296,598 | 1.21B |
| 27 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.08% | 4,348,158 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.75B | -0.03% | 840,236 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | -2.03% | 312,567 | 7.46M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.52B | 5.90% | 566,030 | 51.48M |
| 31 | CORT | Corcept Therapeutics Incorporated | 9.42B | -0.14% | 250,391 | 769.10M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.30B | 1.54% | 835,117 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 9.24B | 0.57% | 5,677,344 | 140.98M |
| 34 | PCVX | Vaxcyte, Inc. | 8.57B | 2.88% | 804,325 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 7.99B | 2.18% | 143,118 | 74.06M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.89B | -0.04% | 1,152,314 | 700.35M |
| 37 | IMVT | Immunovant, Inc. | 7.89B | -0.26% | 594,079 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.87B | 0.49% | 826,867 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.68B | 1.78% | 367,707 | 217.17M |
| 40 | ABVX | ABIVAX Société Anonyme | 7.58B | 39.00% | 6,665,113 | 5.67M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.31B | -2.54% | 431,506 | 569.61M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.84B | 1.10% | 1,013,007 | 827.11M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.74B | 1.81% | 3,226,402 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.67B | 1.22% | 828,205 | - |
| 45 | CGON | CG Oncology, Inc. | 6.37B | -2.03% | 584,412 | 5.07M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.31B | 0.27% | 445,607 | 274.48M |
| 47 | DFTX | Definium Therapeutics, Inc. | 6.27B | 1.46% | 2,345,285 | - |
| 48 | BLTE | Belite Bio, Inc | 6.06B | -0.46% | 135,821 | - |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.89B | 5.67% | 765,496 | - |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.79B | -0.33% | 504,203 | 7.50M |
| 51 | ERAS | Erasca, Inc. | 5.68B | -0.05% | 2,360,351 | - |
| 52 | LEGN | Legend Biotech Corporation | 5.60B | -1.46% | 399,615 | 1.14B |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.39B | -0.63% | 606,357 | 536.20M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 5.34B | 2.06% | 559,162 | 1.34M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.34B | -1.79% | 628,077 | 4.10M |
| 56 | MANE | Veradermics, Incorporated | 5.26B | 1.92% | 312,271 | - |
| 57 | CELC | Celcuity Inc. | 5.09B | 1.86% | 494,750 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 5.01B | -3.17% | 1,378,607 | 907.29M |
| 59 | VKTX | Viking Therapeutics, Inc. | 4.71B | 2.55% | 1,898,978 | - |
| 60 | TNGX | Tango Therapeutics, Inc. | 4.67B | -0.83% | 2,866,455 | 56.99M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.48B | 1.74% | 426,455 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35B | 0.79% | 801,371 | 1.10B |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.17B | -3.14% | 2,657,788 | 10.68M |
| 64 | DNLI | Denali Therapeutics Inc. | 4.16B | 1.35% | 928,526 | - |
| 65 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.96B | 1.65% | 254,805 | 18.07M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.95B | -0.32% | 423,375 | 22.57M |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.88B | -0.76% | 471,655 | 236.00M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.87B | 2.21% | 85,109 | 803.79M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.05% | 4,015,909 | 596.96M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.85B | 4.70% | 574,090 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.77B | 7.15% | 1,269,199 | - |
| 72 | PBLS | Parabilis Medicines, Inc. | 3.73B | 0.41% | 258,871 | - |
| 73 | ALMS | Alumis Inc. | 3.62B | 4.72% | 1,048,000 | 8.40M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.60B | 1.34% | 791,094 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | 1.78% | 957,409 | 225.27M |
| 76 | BEAM | Beam Therapeutics Inc. | 3.52B | 1.26% | 926,032 | 164.01M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.36B | 11.51% | 3,686,817 | 670.00M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | -2.17% | 490,076 | 415.62M |
| 79 | QURE | uniQure N.V. | 3.18B | -2.55% | 964,477 | 18.09M |
| 80 | VERA | Vera Therapeutics, Inc. | 3.15B | 1.58% | 1,208,094 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 3.00B | 2.16% | 1,228,481 | 865.00K |
| 82 | KLRA | Kailera Therapeutics, Inc. | 2.84B | 1.02% | 311,510 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.84B | -0.36% | 306,524 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | 4.55% | 384,419 | 535.08M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.72B | -5.50% | 16,794,868 | - |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.71B | 2.36% | 1,558,999 | - |
| 87 | MBX | MBX Biosciences, Inc. | 2.65B | 3.29% | 494,883 | - |
| 88 | NRIX | Nurix Therapeutics, Inc. | 2.55B | 3.48% | 1,096,536 | 71.78M |
| 89 | PHVS | Pharvaris N.V. | 2.45B | 0.92% | 730,336 | - |
| 90 | KOD | Kodiak Sciences Inc. | 2.43B | 2.99% | 624,558 | - |
| 91 | IMNM | Immunome, Inc. | 2.41B | 1.05% | 579,741 | 4.02M |
| 92 | ABCL | AbCellera Biologics Inc. | 2.38B | -3.94% | 5,724,399 | 79.21M |
| 93 | NKTR | Nektar Therapeutics | 2.38B | 7.54% | 922,129 | 55.63M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -0.89% | 978,789 | - |
| 95 | NTLA | Intellia Therapeutics, Inc. | 2.34B | 0.84% | 1,707,734 | 66.09M |
| 96 | VCEL | Vericel Corporation | 2.28B | -1.04% | 270,271 | 292.09M |
| 97 | GENB | Generate Biomedicines, Inc. | 2.27B | 4.91% | 871,944 | 30.30M |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.25B | -0.58% | 475,428 | 66.05M |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.24B | 0.76% | 264,554 | - |
| 100 | TSHA | Taysha Gene Therapies, Inc. | 2.22B | 3.34% | 3,698,565 | 7.47M |
| 101 | BHVN | Biohaven Ltd. | 2.22B | -1.27% | 1,902,871 | - |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 2.50% | 817,242 | 298.30M |
| 103 | OCUL | Ocular Therapeutix, Inc. | 2.20B | 1.62% | 1,262,983 | 52.04M |
| 104 | KARD | Kardigan, Inc. | 2.19B | -5.37% | 307,656 | - |
| 105 | ZLAB | Zai Lab Limited | 2.14B | 3.64% | 347,658 | 453.28M |
| 106 | HRMY | Harmony Biosciences Holdings, Inc. | 2.09B | 2.09% | 405,828 | 899.11M |
| 107 | VRDN | Viridian Therapeutics, Inc. | 2.09B | 0.53% | 1,661,634 | 70.92M |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 2.05B | 1.38% | 1,019,704 | 42.95M |
| 109 | STOK | Stoke Therapeutics, Inc. | 2.04B | 1.08% | 2,636,963 | 32.08M |
| 110 | RAPP | Rapport Therapeutics, Inc. | 2.03B | 5.10% | 327,814 | 20.00M |
| 111 | PGEN | Precigen, Inc. | 2.03B | -3.89% | 2,168,764 | 31.60M |
| 112 | SION | Sionna Therapeutics, Inc. | 2.02B | 4.24% | 353,649 | - |
| 113 | ANAB | AnaptysBio, Inc. | 2.00B | 4.34% | 237,944 | 232.39M |
| 114 | NUVB | Nuvation Bio Inc. | 1.98B | 1.60% | 6,709,142 | 143.05M |
| 115 | ATAI | AtaiBeckley Inc. | 1.98B | 0.19% | 3,900,262 | 3.49M |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.97B | 2.16% | 1,369,226 | 217.17M |
| 117 | ABSI | Absci Corporation | 1.96B | 2.11% | 3,054,059 | 1.84M |
| 118 | BCAX | Bicara Therapeutics Inc. | 1.95B | 1.09% | 564,390 | - |
| 119 | ZYME | Zymeworks Inc. | 1.95B | 10.58% | 601,663 | 81.26M |
| 120 | ADMA | ADMA Biologics, Inc. | 1.94B | - | 1,118,131 | 509.86M |
| 121 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 1.89% | 52,964 | 1.20B |
| 122 | RXRX | Recursion Pharmaceuticals, Inc. | 1.92B | -1.90% | 15,690,804 | 66.41M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.91B | 0.28% | 249,892 | - |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | 1.66% | 6,054,915 | 285.61M |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | 6.26% | 2,171,081 | 2.18B |
| 126 | GHRS | GH Research PLC | 1.90B | -2.72% | 118,390 | - |
| 127 | AKTS | Aktis Oncology, Inc. | 1.84B | 10.40% | 280,229 | 8.28M |
| 128 | URGN | UroGen Pharma Ltd. | 1.83B | 4.30% | 302,210 | 140.49M |
| 129 | NBTX | Nanobiotix S.A. | 1.80B | 4.14% | 85,203 | 38.27M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.76B | 0.39% | 810,531 | 65.50M |
| 131 | MESO | Mesoblast Limited | 1.75B | -0.73% | 56,449 | 65.38M |
| 132 | COAG | Hemab Therapeutics Holdings, Inc. | 1.70B | -0.68% | 124,165 | - |
| 133 | INVA | Innoviva, Inc. | 1.68B | -1.51% | 192,412 | 420.69M |
| 134 | MAZE | Maze Therapeutics, Inc. | 1.67B | 4.34% | 270,570 | 20.00M |
| 135 | MPLT | MapLight Therapeutics, Inc. | 1.65B | 6.39% | 184,421 | - |
| 136 | FTRE | Fortrea Holdings Inc. | 1.64B | -0.97% | 343,015 | 2.71B |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.64B | 2.53% | 303,650 | - |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.64B | -0.55% | 743,641 | - |
| 139 | IMCR | Immunocore Holdings plc | 1.61B | 4.27% | 300,503 | 412.81M |
| 140 | ZBIO | Zenas BioPharma, Inc. | 1.61B | -0.31% | 233,247 | 10.00M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.58B | -4.23% | 1,568,685 | 204.73M |
| 142 | DMRA | Damora Therapeutics, Inc. | 1.57B | 5.31% | 253,094 | - |
| 143 | SVRA | Savara Inc. | 1.57B | 2.57% | 706,875 | - |
| 144 | AAPG | Ascentage Pharma Group International | 1.56B | -1.13% | 180 | 82.08M |
| 145 | NVAX | Novavax, Inc. | 1.55B | 0.53% | 2,352,543 | 596.34M |
| 146 | SEPN | Septerna, Inc. | 1.54B | -1.87% | 211,564 | 72.26M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.46B | 6.19% | 241,698 | - |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 0.10% | 112,483 | 1.30M |
| 149 | IMTX | Immatics N.V. | 1.40B | 7.32% | 411,865 | 43.00M |
| 150 | CAPR | Capricor Therapeutics, Inc. | 1.40B | 1.51% | 1,044,441 | 11.13M |
| 151 | JBIO | Jade Biosciences, Inc. | 1.34B | 2.40% | 425,923 | - |
| 152 | MNKD | MannKind Corporation | 1.33B | 1.89% | 3,603,323 | 360.78M |
| 153 | ARDX | Ardelyx, Inc. | 1.26B | -2.58% | 4,762,644 | 427.68M |
| 154 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 1.45% | 503,420 | - |
| 155 | XNCR | Xencor, Inc. | 1.23B | 6.47% | 715,231 | 97.36M |
| 156 | MGTX | MeiraGTx Holdings plc | 1.23B | 6.02% | 624,142 | 79.76M |
| 157 | EYPT | EyePoint, Inc. | 1.21B | 2.41% | 1,200,310 | 7.61M |
| 158 | SPTX | Seaport Therapeutics, Inc. | 1.19B | -1.42% | 75,767 | - |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 1.15B | 1.68% | 204,001 | - |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 7.04% | 778,082 | - |
| 161 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.46% | 1,707,645 | 71.80M |
| 162 | DRTS | Alpha Tau Medical Ltd. | 1.11B | 10.07% | 1,508,509 | - |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.09B | -7.20% | 2,782,432 | 69.64M |
| 164 | OLMA | Olema Pharmaceuticals, Inc. | 1.08B | 0.90% | 1,239,849 | - |
| 165 | SANA | Sana Biotechnology, Inc. | 1.06B | 2.61% | 1,291,697 | - |
| 166 | VOR | Vor Biopharma Inc. | 1.01B | 0.43% | 862,426 | - |
| 167 | SLDB | Solid Biosciences Inc. | 1.01B | 8.03% | 1,373,893 | - |
| 168 | KURA | Kura Oncology, Inc. | 989.83M | 1.64% | 771,820 | 71.64M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 979.30M | -3.42% | 1,029,771 | 59.00K |
| 170 | DBVT | DBV Technologies S.A. | 967.91M | 0.66% | 164,372 | 5.74M |
| 171 | JANX | Janux Therapeutics, Inc. | 955.01M | 2.19% | 550,339 | 13.73M |
| 172 | ANRO | Alto Neuroscience, Inc. | 951.75M | -3.38% | 242,055 | - |
| 173 | PHAR | Pharming Group N.V. | 947.75M | 1.23% | 6,357 | 369.49M |
| 174 | LBRX | LB Pharmaceuticals Inc | 946.33M | 1.10% | 187,892 | - |
| 175 | REPL | Replimune Group, Inc. | 944.38M | 0.45% | 2,369,786 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 935.34M | 1.18% | 1,376,141 | 191.45M |
| 177 | DSGN | Design Therapeutics, Inc. | 934.36M | 5.06% | 540,546 | - |
| 178 | ANNX | Annexon, Inc. | 926.53M | 1.53% | 1,468,686 | - |
| 179 | ODTX | Odyssey Therapeutics, Inc. | 895.80M | -0.95% | 217,627 | 1.06M |
| 180 | TBPH | Theravance Biopharma, Inc. | 876.92M | -0.29% | 609,868 | 109.78M |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 873.73M | 1.20% | 284,789 | 204.89M |
| 182 | ZVRA | Zevra Therapeutics, Inc. | 847.12M | 2.28% | 550,881 | 122.29M |
| 183 | CTMX | CytomX Therapeutics, Inc. | 834.89M | 2.54% | 3,183,576 | 35.54M |
| 184 | GERN | Geron Corporation | 827.56M | -0.77% | 6,116,061 | 196.12M |
| 185 | OCS | Oculis Holding AG | 824.90M | 4.35% | 369,850 | 1.40M |
| 186 | IVA | Inventiva S.A. | 816.29M | 4.65% | 1,326,268 | 7.94M |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 809.32M | -4.79% | 463,090 | 98.99M |
| 188 | CADL | Candel Therapeutics, Inc. | 789.12M | 3.96% | 1,818,880 | - |
| 189 | AURA | Aura Biosciences, Inc. | 782.02M | 3.05% | 577,671 | - |
| 190 | IMMX | Immix Biopharma, Inc. | 762.09M | 2.05% | 1,476,400 | - |
| 191 | CLYM | Climb Bio, Inc. | 751.83M | -1.72% | 427,997 | - |
| 192 | SGP | SpyGlass Pharma, Inc. | 740.88M | 2.36% | 31,622 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 737.31M | 2.07% | 138,419 | 299.77M |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 734.63M | 4.78% | 1,923,452 | 8.37M |
| 195 | ALLO | Allogene Therapeutics, Inc. | 731.73M | -4.50% | 10,595,718 | 22.00K |
| 196 | EIKN | Eikon Therapeutics, Inc. | 730.87M | 5.97% | 142,694 | - |
| 197 | RLMD | Relmada Therapeutics, Inc. | 730.04M | -0.29% | 1,007,869 | - |
| 198 | TENX | Tenax Therapeutics, Inc. | 725.76M | 5.22% | 520,183 | - |
| 199 | FDMT | 4D Molecular Therapeutics, Inc. | 723.50M | 7.45% | 603,354 | 88.24M |
| 200 | OMER | Omeros Corporation | 707.83M | -1.31% | 1,190,788 | 9.89M |
| 201 | AGMB | AgomAb Therapeutics NV | 681.59M | -22.33% | 171,912 | - |
| 202 | PRME | Prime Medicine, Inc. | 673.70M | 0.27% | 1,411,569 | 4.03M |
| 203 | DRUG | Bright Minds Biosciences Inc. | 671.06M | 5.42% | 112,275 | - |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 662.96M | 11.70% | 443,591 | - |
| 205 | TECX | Tectonic Therapeutic, Inc. | 660.99M | 5.86% | 92,907 | - |
| 206 | ACHV | Achieve Life Sciences, Inc. | 652.91M | 2.09% | 1,169,285 | - |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 636.91M | -4.51% | 563,864 | 151.40M |
| 208 | FTH | Faeth Therapeutics, Inc. | 634.80M | 6.05% | 72,524 | - |
| 209 | MNPR | Monopar Therapeutics Inc. | 625.00M | -1.33% | 67,266 | - |
| 210 | PROK | ProKidney Corp. | 623.75M | 9.26% | 2,538,827 | 889.00K |
| 211 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 618.03M | 0.72% | 172,534 | - |
| 212 | RGNX | REGENXBIO Inc. | 615.72M | 0.68% | 730,359 | 87.82M |
| 213 | CTNM | Contineum Therapeutics, Inc. | 613.14M | 9.33% | 387,485 | - |
| 214 | CRMD | CorMedix Inc. | 608.79M | 1.57% | 492,491 | 400.05M |
| 215 | GYRE | Gyre Therapeutics, Inc. | 608.54M | 3.26% | 35,899 | 117.05M |
| 216 | ALT | Altimmune, Inc. | 605.79M | 5.95% | 2,680,379 | 36.00K |
| 217 | CBIO | Crescent Biopharma, Inc. | 600.12M | 0.33% | 81,056 | 11.88M |
| 218 | MDXG | MiMedx Group, Inc. | 563.76M | -3.20% | 551,598 | 389.42M |
| 219 | ZURA | Zura Bio Limited | 559.54M | 4.62% | 1,220,351 | - |
| 220 | ASMB | Assembly Biosciences, Inc. | 554.09M | 3.71% | 110,508 | 71.10M |
| 221 | SLBT | SL Science Holding Limited | 547.92M | -0.29% | 46,229 | - |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 547.16M | 2.51% | 746,423 | - |
| 223 | PRLD | Prelude Therapeutics Incorporated | 545.48M | 11.56% | 624,488 | 16.72M |
| 224 | STTK | Shattuck Labs, Inc. | 544.43M | 3.65% | 1,396,982 | 1.00M |
| 225 | ARVN | Arvinas, Inc. | 544.24M | 1.75% | 217,922 | 89.40M |
| 226 | STRO | Sutro Biopharma, Inc. | 543.84M | -1.59% | 149,035 | 99.61M |
| 227 | FBRX | Forte Biosciences, Inc. | 541.37M | 3.92% | 238,860 | - |
| 228 | OCGN | Ocugen, Inc. | 533.17M | -5.69% | 6,958,932 | 4.47M |
| 229 | XOMA | XOMA Royalty Corporation | 529.73M | 0.21% | 86,798 | 48.56M |
| 230 | RZLT | Rezolute, Inc. | 526.51M | -1.18% | 1,318,724 | - |
| 231 | PRTA | Prothena Corporation plc | 523.53M | 0.30% | 89,820 | 57.94M |
| 232 | CCCC | C4 Therapeutics, Inc. | 518.01M | 7.70% | 4,406,963 | 34.86M |
| 233 | SLN | Silence Therapeutics plc | 514.85M | 1.02% | 276,436 | 839.00K |
| 234 | CABA | Cabaletta Bio, Inc. | 511.99M | 0.96% | 2,835,986 | - |
| 235 | NGNE | Neurogene Inc. | 506.92M | -0.62% | 91,575 | 925.00K |
| 236 | OVID | Ovid Therapeutics Inc. | 503.93M | -0.74% | 1,866,184 | 7.12M |
| 237 | EVMN | Evommune, Inc. | 497.05M | -8.31% | 943,395 | 10.00M |
| 238 | EDIT | Editas Medicine, Inc. | 494.15M | 0.63% | 941,387 | 38.69M |
| 239 | VALN | Valneva SE | 488.58M | 1.55% | 30,185 | 180.25M |
| 240 | NVCT | Nuvectis Pharma, Inc. | 479.85M | -36.59% | 2,106,778 | - |
| 241 | ARTV | Artiva Biotherapeutics, Inc. | 475.68M | 2.19% | 291,655 | 251.00K |
| 242 | VTVT | vTv Therapeutics Inc. | 470.82M | 4.60% | 71,730 | 36.84M |
| 243 | ANL | Adlai Nortye Ltd. | 470.00M | 2.98% | 96,273 | 5.00M |
| 244 | BNTC | Benitec Biopharma Inc. | 461.04M | 5.67% | 20,957 | - |
| 245 | SGMT | Sagimet Biosciences Inc. | 460.67M | -4.24% | 347,114 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 447.28M | 2.90% | 2,353,688 | 109.16M |
| 247 | AUTL | Autolus Therapeutics plc | 433.81M | -1.21% | 608,705 | 92.62M |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 429.86M | 0.46% | 132,098 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 423.53M | 0.38% | 68,754 | 69.21M |
| 250 | HELP | Cybin Inc. | 421.49M | -1.16% | 987,110 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 417.84M | 4.73% | 444,397 | 9.01M |
| 252 | PBYI | Puma Biotechnology, Inc. | 414.32M | -0.61% | 116,451 | 227.18M |
| 253 | CMPX | Compass Therapeutics, Inc. | 407.00M | 4.63% | 1,447,959 | 850.00K |
| 254 | DMAC | DiaMedica Therapeutics Inc. | 388.50M | -0.14% | 186,190 | - |
| 255 | UPB | Upstream Bio, Inc. | 386.65M | 2.53% | 295,410 | 3.32M |
| 256 | PALI | Palisade Bio, Inc. | 381.88M | -1.35% | 3,361,563 | - |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 373.77M | -2.45% | 80,314 | 51.00M |
| 258 | RCKT | Rocket Pharmaceuticals, Inc. | 372.90M | 1.34% | 694,906 | - |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 371.41M | -1.66% | 403,449 | - |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 370.13M | 0.33% | 123,824 | - |
| 261 | OABI | OmniAb, Inc. | 369.68M | -0.78% | 200,907 | 28.94M |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 368.33M | -0.24% | 290,618 | 217.78M |
| 263 | ZNTL | Zentalis Pharmaceuticals, Inc. | 355.93M | 8.46% | 991,986 | 26.87M |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 352.28M | 3.23% | 76,004 | - |
| 265 | VSTM | Verastem, Inc. | 347.54M | 3.53% | 1,687,516 | 49.59M |
| 266 | IFRX | InflaRx N.V. | 346.14M | 3.07% | 879,972 | 33.82K |
| 267 | ABEO | Abeona Therapeutics Inc. | 343.97M | 6.63% | 1,371,195 | 14.54M |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 341.70M | 3.89% | 1,040,474 | 1.00 |
| 269 | INDP | Indaptus Therapeutics, Inc. | 337.46M | -2.61% | 65,112 | - |
| 270 | IRD | Opus Genetics, Inc. | 332.09M | 0.49% | 313,247 | 11.98M |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 331.57M | -1.48% | 398,647 | 14.78M |
| 272 | LRMR | Larimar Therapeutics, Inc. | 322.54M | -3.44% | 2,088,553 | - |
| 273 | IMRX | Immuneering Corporation | 320.58M | -1.88% | 775,292 | - |
| 274 | NMRA | Neumora Therapeutics, Inc. | 313.13M | -1.74% | 785,958 | - |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 307.66M | 2.58% | 752,282 | - |
| 276 | FATE | Fate Therapeutics, Inc. | 300.72M | 6.61% | 4,461,327 | 6.32M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 299.74M | 0.51% | 207,312 | 114.70K |
| 278 | SRZN | Surrozen, Inc. | 298.15M | -0.16% | 51,066 | 7.49M |
| 279 | BCYC | Bicycle Therapeutics plc | 297.40M | 2.65% | 184,730 | 63.50M |
| 280 | LYEL | Lyell Immunopharma, Inc. | 293.89M | -1.22% | 85,499 | 31.00K |
| 281 | MGNX | MacroGenics, Inc. | 292.39M | -5.35% | 365,409 | 157.08M |
| 282 | CNXU | Conexeu Sciences Inc. | 288.45M | 5.27% | 15,271 | - |
| 283 | RNAC | Cartesian Therapeutics, Inc. | 287.94M | 1.66% | 104,717 | 1.78M |
| 284 | FHTX | Foghorn Therapeutics Inc. | 285.64M | 0.10% | 111,914 | 28.22M |
| 285 | ADAG | Adagene Inc. | 282.79M | 1.18% | 245,747 | 7.67M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 281.24M | -5.00% | 417,592 | - |
| 287 | GALT | Galectin Therapeutics Inc. | 275.94M | -15.69% | 815,238 | - |
| 288 | TRDA | Entrada Therapeutics, Inc. | 273.49M | -1.56% | 168,976 | 5.74M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 267.07M | -6.11% | 216,183 | 32.72M |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 259.20M | 4.29% | 728,386 | 80.00M |
| 291 | IVVD | Invivyd, Inc. | 257.52M | -7.38% | 1,681,691 | 55.87M |
| 292 | NERV | Minerva Neurosciences, Inc. | 256.94M | 1.57% | 95,127 | - |
| 293 | NAGE | Niagen Bioscience, Inc. | 256.19M | -2.73% | 323,859 | 130.42M |
| 294 | WHWK | Whitehawk Therapeutics, Inc. | 250.36M | 5.56% | 348,667 | 7.15M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 246.25M | 1.24% | 10,403 | 18.47M |
| 296 | AVXL | Anavex Life Sciences Corp. | 242.34M | 0.58% | 422,369 | - |
| 297 | ARMP | Armata Pharmaceuticals, Inc. | 241.92M | 2.01% | 41,598 | 5.20M |
| 298 | ACIU | AC Immune SA | 238.58M | -9.59% | 383,103 | 4.62M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 236.37M | 3.91% | 410,480 | - |
| 300 | RNA | Atrium Therapeutics, Inc. | 230.24M | -1.39% | 131,709 | 36.68M |
| 301 | NBP | NovaBridge Biosciences | 228.41M | -0.25% | 624,717 | - |
| 302 | KPTI | Karyopharm Therapeutics Inc. | 225.95M | -1.14% | 398,662 | 151.12M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 224.58M | -2.59% | 158,903 | 3.93M |
| 304 | TARA | Protara Therapeutics, Inc. | 224.54M | -3.97% | 1,090,696 | - |
| 305 | QTTB | Q32 Bio Inc. | 224.33M | -6.44% | 321,900 | 53.74M |
| 306 | ALEC | Alector, Inc. | 221.50M | -4.09% | 378,875 | 18.42M |
| 307 | CHRS | Coherus Oncology, Inc. | 221.35M | -1.03% | 289,707 | 46.88M |
| 308 | NGEN | NervGen Pharma Corp. | 216.65M | 4.08% | 580,201 | - |
| 309 | KROS | Keros Therapeutics, Inc. | 215.93M | -0.18% | 144,582 | 33.18M |
| 310 | HUMA | Humacyte, Inc. | 214.71M | -0.33% | 10,510,733 | 2.02M |
| 311 | CLLS | Cellectis S.A. | 214.33M | 2.04% | 8,177 | 75.11M |
| 312 | VYGR | Voyager Therapeutics, Inc. | 213.29M | -1.40% | 227,992 | 36.49M |
| 313 | TTRX | Turn Therapeutics Inc. | 212.98M | 3.47% | 26,202 | - |
| 314 | IMUX | Immunic, Inc. | 210.66M | 0.36% | 69,562 | - |
| 315 | CDXS | Codexis, Inc. | 210.43M | -0.64% | 469,685 | 78.09M |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 205.16M | 0.94% | 167,985 | 17.56M |
| 317 | CGEN | Compugen Ltd. | 204.78M | 0.23% | 149,230 | 72.66M |
| 318 | DTIL | Precision BioSciences, Inc. | 204.48M | 0.06% | 328,981 | 45.07M |
| 319 | NKTX | Nkarta, Inc. | 199.97M | -1.93% | 159,230 | - |
| 320 | EQ | Equillium, Inc. | 198.53M | 1.95% | 3,846,830 | 4.39M |
| 321 | ORMP | Oramed Pharmaceuticals Inc. | 196.85M | 3.66% | 198,039 | 2.00M |
| 322 | ARCT | Arcturus Therapeutics Holdings Inc. | 196.26M | 1.25% | 197,797 | 54.71M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 195.74M | -2.17% | 373,342 | - |
| 324 | OTLK | Outlook Therapeutics, Inc. | 194.59M | -4.73% | 4,596,297 | 333.14K |
| 325 | PRQR | ProQR Therapeutics N.V. | 193.87M | 0.55% | 555,348 | 15.73M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 191.96M | -1.08% | 487,623 | - |
| 327 | KRRO | Korro Bio, Inc. | 189.58M | -0.38% | 44,559 | 3.84M |
| 328 | MDWD | MediWound Ltd. | 188.41M | -2.79% | 15,272 | 14.48M |
| 329 | PYXS | Pyxis Oncology, Inc. | 188.17M | 3.85% | 6,278,260 | 13.86M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 187.33M | -1.06% | 208,604 | 76.38M |
| 331 | OKUR | OnKure Therapeutics, Inc. | 185.42M | 2.00% | 173,182 | - |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 184.40M | 1.91% | 1,481,266 | 1.78M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 182.24M | 0.60% | 36,935 | - |
| 334 | LENZ | LENZ Therapeutics, Inc. | 178.09M | -1.39% | 730,559 | 20.99M |
| 335 | CRBU | Caribou Biosciences, Inc. | 176.54M | 0.56% | 772,980 | 11.20M |
| 336 | IPHA | Innate Pharma S.A. | 173.66M | 2.44% | 5,006 | 10.57M |
| 337 | NRXP | NRx Pharmaceuticals, Inc. | 172.67M | 3.00% | 473,116 | 2.29M |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 169.71M | 2.00% | 211,843 | - |
| 339 | KZIA | Kazia Therapeutics Limited | 164.55M | -0.41% | 69,854 | 1.27M |
| 340 | TLSA | Tiziana Life Sciences Ltd | 161.63M | 1.63% | 47,411 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 160.58M | 0.69% | 563,990 | 225.00K |
| 342 | YDES | YD Bio Limited | 160.33M | -5.79% | 7,038 | 510.36K |
| 343 | MENS | Jyong Biotech Ltd. | 157.00M | -3.86% | 93,335 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 156.15M | 4.20% | 315,919 | 233.00K |
| 345 | SPRB | Spruce Biosciences, Inc. | 152.48M | -0.86% | 69,626 | 697.00K |
| 346 | ACOG | Alpha Cognition Inc. | 151.55M | 2.20% | 18,454 | 10.83M |
| 347 | MOLN | Molecular Partners AG | 147.57M | -3.91% | 600 | 856.30K |
| 348 | HURA | TuHURA Biosciences, Inc. | 147.11M | 0.87% | 397,584 | - |
| 349 | COYA | Coya Therapeutics, Inc. | 141.33M | -0.74% | 231,547 | 7.94M |
| 350 | ADCT | ADC Therapeutics SA | 138.00M | 5.34% | 521,124 | 79.18M |
| 351 | CUE | Cue Biopharma, Inc. | 135.83M | 10.34% | 189,775 | 32.73M |
| 352 | ENLV | Enlivex Ltd. | 133.20M | -4.72% | 307,928 | - |
| 353 | GNLX | Genelux Corporation | 130.78M | 1.55% | 79,241 | 8.00K |
| 354 | SPRO | Spero Therapeutics, Inc. | 129.41M | -1.11% | 302,370 | 61.19M |
| 355 | PLYX | Polaryx Therapeutics, Inc. | 129.25M | 7.91% | 135,663 | - |
| 356 | UNCY | Unicycive Therapeutics, Inc. | 129.23M | -37.14% | 17,177,619 | - |
| 357 | AGEN | Agenus Inc. | 128.68M | -1.90% | 320,363 | 123.87M |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 127.28M | 2.93% | 1,095,111 | - |
| 359 | PEPG | PepGen Inc. | 124.85M | 1.40% | 189,464 | - |
| 360 | GUTS | Fractyl Health, Inc. | 123.81M | -1.91% | 272,723 | 3.00K |
| 361 | AARD | Aardvark Therapeutics, Inc. | 122.17M | 8.11% | 142,395 | - |
| 362 | ENGN | enGene Therapeutics Inc. | 118.24M | -0.84% | 795,196 | - |
| 363 | PMN | ProMIS Neurosciences, Inc. | 113.89M | 18.14% | 240,044 | - |
| 364 | NTHI | NeOnc Technologies Holdings, Inc. | 112.15M | - | 16,870 | 39.99K |
| 365 | ONCY | Oncolytics Biotech Inc. | 111.51M | -2.83% | 424,959 | - |
| 366 | CBUS | Cibus, Inc. | 110.68M | 1.40% | 120,685 | 4.29M |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 107.20M | -4.00% | 25,521 | 37.16M |
| 368 | BMEA | Biomea Fusion, Inc. | 106.28M | 5.76% | 1,141,214 | - |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 104.58M | 4.29% | 895,275 | 70.00M |
| 370 | VANI | Vivani Medical, Inc. | 104.34M | - | 94,660 | - |
| 371 | CGTX | Cognition Therapeutics, Inc. | 103.85M | 6.46% | 592,808 | - |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 103.53M | 2.86% | 65,719 | 23.14M |
| 373 | FBIO | Fortress Biotech, Inc. | 99.99M | 2.03% | 312,098 | 66.16M |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 99.93M | -0.36% | 27,397 | - |
| 375 | ALPS | Alps Group Inc | 99.42M | 1.27% | 6,932 | 3.74M |
| 376 | PYPD | PolyPid Ltd. | 96.25M | 1.01% | 214,938 | - |
| 377 | PTHS | Pelthos Therapeutics Inc. | 96.00M | 0.25% | 37,325 | 27.70M |
| 378 | ANIX | Anixa Biosciences, Inc. | 94.95M | -2.08% | 169,152 | - |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 94.68M | -0.05% | 152,904 | 3.17M |
| 380 | RNTX | Rein Therapeutics Inc. | 93.04M | -3.85% | 373,752 | - |
| 381 | SEER | Seer, Inc. | 92.64M | 1.51% | 113,740 | 15.17M |
| 382 | ICCC | ImmuCell Corporation | 91.92M | 2.52% | 56,576 | 29.93M |
| 383 | LIXT | Lixte Biotechnology Holdings, Inc. | 91.63M | -7.96% | 157,613 | - |
| 384 | INO | Inovio Pharmaceuticals, Inc. | 89.68M | -2.68% | 863,873 | 65.34K |
| 385 | ACET | Adicet Bio, Inc. | 89.57M | -0.35% | 60,398 | - |
| 386 | GANX | Gain Therapeutics, Inc. | 87.65M | 3.79% | 3,132,661 | - |
| 387 | CRDF | Cardiff Oncology, Inc. | 87.51M | 0.79% | 248,548 | 525.00K |
| 388 | MAIA | MAIA Biotechnology, Inc. | 87.25M | -3.04% | 371,459 | - |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 87.00M | 1.20% | 31,019 | - |
| 390 | OSTX | OS Therapies Incorporated | 86.85M | -12.95% | 1,372,291 | - |
| 391 | CSBR | Champions Oncology, Inc. | 86.51M | -3.11% | 3,290 | 57.95M |
| 392 | LONA | LeonaBio, Inc. | 86.28M | 3.67% | 5,597 | - |
| 393 | IBIO | iBio, Inc. | 86.19M | 0.29% | 208,311 | 300.00K |
| 394 | ATHE | Alterity Therapeutics Limited | 86.06M | 10.63% | 69,784 | 4.43M |
| 395 | NRXS | NeurAxis, Inc. | 85.58M | -3.22% | 91,541 | 4.28M |
| 396 | RLYB | Rallybio Corporation | 84.90M | -0.22% | 11,511 | 858.00K |
| 397 | GOSS | Gossamer Bio, Inc. | 83.35M | 3.96% | 6,381,864 | 55.54M |
| 398 | ENTX | Entera Bio Ltd. | 80.98M | -0.30% | 142,650 | 42.00K |
| 399 | HRTX | Heron Therapeutics, Inc. | 80.22M | -2.69% | 1,664,308 | 150.71M |
| 400 | HYFT | MindWalk Holdings Corp. | 79.96M | -3.01% | 145,277 | 20.70M |
| 401 | ANVS | Annovis Bio, Inc. | 78.70M | -0.54% | 443,254 | - |
| 402 | OKYO | OKYO Pharma Limited | 78.19M | -1.97% | 91,729 | - |
| 403 | MCRB | Seres Therapeutics, Inc. | 77.18M | 2.31% | 64,144 | 1.15M |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 76.19M | - | 142,292 | - |
| 405 | CING | Cingulate Inc. | 74.35M | 3.76% | 195,803 | - |
| 406 | ELTX | Elicio Therapeutics, Inc. | 73.24M | -4.00% | 246,503 | - |
| 407 | BYSI | BeyondSpring Inc. | 73.19M | -0.56% | 17,767 | 1.88M |
| 408 | EDSA | Edesa Biotech, Inc. | 72.56M | 6.39% | 155,175 | - |
| 409 | EXOZ | eXoZymes, Inc. | 71.48M | 0.12% | 14,401 | -700.00 |
| 410 | XBIT | XBiotech Inc. | 71.04M | - | 9,636 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 70.13M | 1.94% | 213,742 | - |
| 412 | PLRX | Pliant Therapeutics, Inc. | 69.74M | -1.30% | 144,903 | - |
| 413 | IMA | ImageneBio, Inc. | 67.00M | -2.14% | 3,989 | 800.00K |
| 414 | MNOV | MediciNova, Inc. | 65.01M | 0.82% | 32,867 | 596.64K |
| 415 | TCRX | TScan Therapeutics, Inc. | 63.11M | -1.21% | 440,695 | 9.14M |
| 416 | INKT | MiNK Therapeutics, Inc. | 59.28M | -0.08% | 8,992 | - |
| 417 | FLNA | Filana Therapeutics, Inc. | 57.73M | -2.05% | 149,369 | - |
| 418 | ATYR | aTyr Pharma, Inc. | 57.53M | 3.59% | 732,221 | 190.00K |
| 419 | XLO | Xilio Therapeutics, Inc. | 57.27M | 3.25% | 12,131 | 53.48M |
| 420 | BOLD | Boundless Bio, Inc. | 56.21M | 2.14% | 636,330 | - |
| 421 | DWTX | Dogwood Therapeutics, Inc. | 56.16M | -6.18% | 12,657 | - |
| 422 | IMMP | Immutep Limited | 53.74M | 1.47% | 326,771 | 5.28M |
| 423 | IBO | Impact BioMedical Inc. | 52.44M | -3.36% | 98,162 | 39.00K |
| 424 | LTRN | Lantern Pharma Inc. | 52.18M | 0.49% | 50,113 | - |
| 425 | CNTX | Context Therapeutics Inc. | 51.95M | -2.03% | 1,875,579 | - |
| 426 | MREO | Mereo BioPharma Group plc | 51.68M | -2.41% | 372,323 | 500.00K |
| 427 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.66M | 7.29% | 21,689 | - |
| 428 | TIL | Instil Bio, Inc. | 51.16M | 0.18% | 5,906 | - |
| 429 | VERU | Veru Inc. | 50.24M | 0.32% | 106,217 | 16.89M |
| 430 | VRXA | Veraxa Biotech AG | 50.18M | -8.29% | 184,867 | - |
| 431 | PDSB | PDS Biotechnology Corporation | 49.08M | -2.19% | 128,075 | - |
| 432 | HYPD | Hyperion DeFi, Inc. | 46.99M | -2.52% | 223,237 | 1.04M |
| 433 | RADX | Radiopharm Theranostics Limited | 46.59M | 1.69% | 16,835 | 10.86M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 44.61M | -1.25% | 139,577 | 22.33M |
| 435 | INMB | INmune Bio Inc. | 43.87M | 1.85% | 333,267 | 50.00K |
| 436 | RNXT | RenovoRx, Inc. | 43.57M | -0.41% | 110,164 | 1.49M |
| 437 | APLM | Apollomics, Inc. | 43.31M | -7.16% | 5,452 | 8.84M |
| 438 | CRVO | CervoMed Inc. | 43.28M | 1.59% | 346,340 | 2.09M |
| 439 | GNTA | Genenta Science S.p.A. | 43.17M | 1.67% | 126,379 | - |
| 440 | ESLA | Estrella Immunopharma, Inc. | 41.96M | -5.34% | 24,498 | - |
| 441 | ABVC | ABVC BioPharma, Inc. | 39.93M | 0.64% | 143,086 | 797.92K |
| 442 | NTRB | Nutriband Inc. | 38.66M | -0.93% | 8,473 | 1.80M |
| 443 | GRCE | Grace Therapeutics, Inc. | 37.10M | -0.87% | 332,852 | - |
| 444 | ACTU | Actuate Therapeutics, Inc. | 36.49M | -3.48% | 71,531 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 36.08M | 7.37% | 58,736 | 4.71M |
| 446 | SNTI | Senti Biosciences Holdings, Inc. | 34.57M | - | 36,635 | 38.00K |
| 447 | DYAI | Dyadic International, Inc. | 33.16M | 3.40% | 58,409 | 3.81M |
| 448 | KALA | KALA BIO, Inc. | 32.72M | -15.79% | 210,173 | - |
| 449 | LITS | Lite Strategy, Inc. | 32.08M | 3.67% | 353,935 | - |
| 450 | NNVC | NanoViricides, Inc. | 31.55M | 1.09% | 195,992 | - |
| 451 | KYNB | Kyntra Bio, Inc. | 31.04M | 4.91% | 7,317 | 7.44M |
| 452 | GRDX | GridAI Technologies Corp. | 30.94M | 4.26% | 53,792 | - |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 30.75M | -0.99% | 96,438 | 90.00K |
| 454 | DARE | Daré Bioscience, Inc. | 30.71M | -2.38% | 97,830 | 1.16M |
| 455 | LSTA | Lisata Therapeutics, Inc. | 30.60M | -0.88% | 1,613 | 170.00K |
| 456 | PSTV | Plus Therapeutics, Inc. | 30.11M | 1.98% | 108,843 | 5.18M |
| 457 | SER | Serina Therapeutics, Inc. | 27.90M | -5.58% | 26,019 | 130.00K |
| 458 | IGC | IGC Pharma, Inc. | 27.58M | 1.66% | 180,628 | 1.11M |
| 459 | BCTX | BriaCell Therapeutics Corp. | 27.06M | 7.10% | 101,110 | - |
| 460 | BRNS | Barinthus Biotherapeutics plc | 27.00M | 0.06% | 9,532 | 14.97M |
| 461 | EVAX | Evaxion A/S | 26.77M | 0.31% | 9,816 | 7.53M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 25.10M | 0.03% | 90,516 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 24.84M | 2.05% | 39,945 | 3.55M |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 24.16M | 1.59% | 25,554 | -13.27K |
| 465 | SKYE | Skye Bioscience, Inc. | 24.15M | 2.51% | 53,656 | - |
| 466 | PLRZ | Polyrizon Ltd. | 24.15M | 1.18% | 4,668 | - |
| 467 | TVGN | Tevogen Bio Holdings Inc. | 24.06M | -8.66% | 16,395 | - |
| 468 | QNTM | Quantum BioPharma Ltd. | 23.87M | -2.43% | 52,639 | - |
| 469 | PLUR | Pluri Inc. | 22.66M | -2.33% | 5,245 | 1.08M |
| 470 | VYNE | VYNE Therapeutics Inc. | 21.85M | 1.16% | 46,729 | 454.00K |
| 471 | LGVN | Longeveron Inc. | 21.80M | -1.39% | 219,025 | 1.22M |
| 472 | CLRB | Cellectar Biosciences, Inc. | 21.62M | 4.04% | 75,448 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 20.84M | 0.77% | 136,281 | 345.00K |
| 474 | LPCN | Lipocine Inc. | 20.53M | - | 6,463 | 2.00M |
| 475 | PTN | Palatin Technologies, Inc. | 19.89M | 5.71% | 10,501 | 12.88M |
| 476 | NCEL | NewcelX Ltd. | 19.84M | -0.14% | 6,586 | - |
| 477 | CRIS | Curis, Inc. | 19.43M | 9.95% | 6,865,066 | 7.06M |
| 478 | AEON | AEON Biopharma, Inc. | 19.02M | -2.23% | 8,446 | - |
| 479 | KTTA | Pasithea Therapeutics Corp. | 18.73M | 6.56% | 24,208,332 | - |
| 480 | CVM | CEL-SCI Corporation | 18.35M | -2.78% | 145,112 | - |
| 481 | CELU | Celularity Inc. | 17.73M | 1.02% | 46,220 | 26.55M |
| 482 | TVRD | Tvardi Therapeutics, Inc. | 17.64M | -1.57% | 323,848 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 17.48M | -2.92% | 79,729 | - |
| 484 | GTBP | GT Biopharma, Inc. | 17.23M | 8.59% | 1,159,485 | - |
| 485 | HOWL | Werewolf Therapeutics, Inc. | 17.07M | 14.03% | 762,252 | 1.14M |
| 486 | ATOS | Atossa Therapeutics, Inc. | 16.71M | -2.02% | 47,371 | - |
| 487 | TPST | Tempest Therapeutics, Inc. | 16.36M | 0.45% | 80,955 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 16.18M | 1.85% | 112,540 | 5.61M |
| 489 | PASG | Passage Bio, Inc. | 15.57M | 0.10% | 50,546 | - |
| 490 | MLEC | Moolec Science SA | 15.44M | -8.28% | 6,976 | 7.83M |
| 491 | HIND | Vyome Holdings, Inc. | 15.02M | 0.48% | 5,264 | 152.72K |
| 492 | BIVI | BioVie Inc. | 14.71M | -2.99% | 78,739 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 14.68M | 2.82% | 34,022 | 1.44M |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.61M | 2.91% | 42,264 | 225.00K |
| 495 | CYCN | Cyclerion Therapeutics, Inc. | 14.38M | 1.04% | 10,876 | 1.99M |
| 496 | LEXX | Lexaria Bioscience Corp. | 14.35M | 1.81% | 32,484 | 368.00K |
| 497 | CALC | CalciMedica, Inc. | 14.23M | -8.71% | 513,826 | - |
| 498 | INAB | IN8bio, Inc. | 14.23M | 1.05% | 1,055 | - |
| 499 | LNAI | Lunai Bioworks Inc. | 14.10M | -1.89% | 50,034 | 20.94K |
| 500 | MBRX | Moleculin Biotech, Inc. | 14.09M | -26.05% | 2,391,482 | - |